Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2003 1
2005 1
2008 1
2010 1
2011 5
2012 5
2013 5
2014 3
2015 2
2016 5
2017 5
2018 5
2019 2
2020 6
2021 3
2022 11
2023 10
2024 7
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Tumor-Secreted Extracellular Vesicles Counteract Therapy Response by Triggering Inflammatory Mesenchymal Stem Cell Development.
Massaro C, Sensoy HN, Mulders M, De Schrijver C, Gómez-Martín C, Simon Nieto J, Lagerweij T, Atmopawiro A, Pérez-Boza J, Bebelman M, Bosch L, Foderaro S, Neves Ferreira M, van Eijndhoven MAJ, van Weering JRT, Dell'Aversana C, Altucci L, Savci-Heijink CD, van de Donk NWCJ, Giorgio C, Brandolini L, Allegretti M, Pegtel DM, Baglio SR. Massaro C, et al. Among authors: gomez martin c. Clin Cancer Res. 2024 Oct 15;30(20):4714-4728. doi: 10.1158/1078-0432.CCR-23-4097. Clin Cancer Res. 2024. PMID: 39115426
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study.
Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Lordick Obermannová R, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Buges Sanchez C, Chau I, Lorenzen S, Daum S, Sinn M, Merelli B, van Grieken NCT, Nilsson M, Collienne M, Giraut A, Smyth E. Lordick F, et al. Among authors: gomez martin c. Ann Oncol. 2025 Feb;36(2):197-207. doi: 10.1016/j.annonc.2024.10.829. Epub 2024 Nov 13. Ann Oncol. 2025. PMID: 39542422 Free article. Clinical Trial.
Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study.
de la Torre-Aláez M, Matilla A, Varela M, Iñarrairaegui M, Reig M, Lledó JL, Arenas JI, Lorente S, Testillano M, Márquez L, Da Fonseca L, Argemí J, Gómez-Martin C, Rodriguez-Fraile M, Bilbao JI, Sangro B. de la Torre-Aláez M, et al. Among authors: gomez martin c. J Immunother Cancer. 2022 Nov;10(11):e005457. doi: 10.1136/jitc-2022-005457. J Immunother Cancer. 2022. PMID: 36450386 Free PMC article. Clinical Trial.
Compositional Structure of the Genome: A Review.
Bernaola-Galván P, Carpena P, Gómez-Martín C, Oliver JL. Bernaola-Galván P, et al. Among authors: gomez martin c. Biology (Basel). 2023 Jun 13;12(6):849. doi: 10.3390/biology12060849. Biology (Basel). 2023. PMID: 37372134 Free PMC article. Review.
[Cytomegalovirus reactivation in patients with immune-mediated gastritis].
Paredes-Ruiz D, López-López F, Núñez-Sobrino JA, Gómez-Martin C, Díaz-Pedroche C, Lizasoain M. Paredes-Ruiz D, et al. Among authors: gomez martin c. Enferm Infecc Microbiol Clin (Engl Ed). 2023 May;41(5):298-300. doi: 10.1016/j.eimce.2022.03.017. Epub 2023 Jan 19. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 36681573 Review. Spanish.
Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
Alsina Maqueda M, Teijo Quintáns A, Cuatrecasas M, Fernández Aceñero MJ, Fernández Montes A, Gómez Martín C, Jiménez Fonseca P, Martínez Ciarpaglini C, Rivera Herrero F, Iglesias Coma M. Alsina Maqueda M, et al. Among authors: gomez martin c. Clin Transl Oncol. 2025 Sep;27(9):3580-3594. doi: 10.1007/s12094-025-03865-6. Epub 2025 Mar 12. Clin Transl Oncol. 2025. PMID: 40072752 Free PMC article. Review.
Circulating extracellular vesicle isomiR signatures predict therapy response in patients with multiple myeloma.
Gómez-Martín C, Drees EEE, van Eijndhoven MAJ, Groenewegen NJ, Wang S, Verkuijlen SAWM, van Weering JRT, Aparicio-Puerta E, Bosch L, Frerichs KA, Verkleij CPM, Kersten MJ, Zijlstra JM, de Jong D, Groothuis-Oudshoorn CGM, Hackenberg M, de Rooij JR, van de Donk NWCJ, Pegtel DM. Gómez-Martín C, et al. Cell Rep Med. 2025 Sep 16:102358. doi: 10.1016/j.xcrm.2025.102358. Online ahead of print. Cell Rep Med. 2025. PMID: 40961943 Free article.
SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021).
Fernández-Montes A, Alcaide J, Alsina M, Custodio AB, Franco LF, Gallego Plazas J, Gómez-Martín C, Richart P, Rivera F, Martin-Richard M. Fernández-Montes A, et al. Among authors: gomez martin c. Clin Transl Oncol. 2022 Apr;24(4):658-669. doi: 10.1007/s12094-022-02801-2. Epub 2022 Mar 26. Clin Transl Oncol. 2022. PMID: 35347573 Free PMC article. Review.
77 results